肝内胆汁淤积对慢性乙型肝炎患者肝硬度的影响:1197例肝活检患者研究
研究纳入1197例慢性乙型肝炎患者,比较总胆红素正常与异常组在各纤维化分期、ALT水平和炎症分级下的二维剪切波弹性成像肝硬度值,并分析将总胆红素加入肝硬度对纤维化分期的诊断价值。结果显示胆红素异常组肝硬度值更高、最佳截断值更高、假阳性率更高,但将总胆红素加入肝硬度并未改善纤维化分期的整体诊断性能。
要点
- 同一纤维化分期下,总胆红素异常患者肝硬度值显著高于总胆红素正常者。
- 总胆红素异常患者各纤维化分期的最佳截断值均高于总胆红素正常者。
- 总胆红素异常患者肝硬度评估纤维化分期的假阳性率高于总胆红素正常者。
核心结论
- 肝内胆汁淤积对慢性乙型肝炎患者肝硬度测量有轻微影响,并导致肝纤维化分期被高估。
- 将总胆红素水平加入肝硬度并未改善肝纤维化分期的整体诊断性能。
研究设计与样本
- 研究类型为纳入慢性乙型肝炎感染患者的临床研究,2011年7月至2016年9月共纳入1197例患者,最终分析973例。
- 收集临床、生物学、二维剪切波弹性成像(2D SWE)及组织学(METAVIR评分系统)数据。
- 以肝活检组织学METAVIR评分为参考标准,比较总胆红素正常与异常组在各纤维化分期、ALT水平和炎症分级亚组中的肝硬度值。
- 采用逻辑回归和ROC分析评估将总胆红素加入肝硬度对纤维化分期的增益价值。
诊断标准与关键数值
- 总胆红素异常患者肝硬度诊断≥F2、≥F3、F4的最佳截断值分别为10.46 kPa、10.94 kPa、15.88 kPa。
- 总胆红素正常患者肝硬度诊断≥F2、≥F3、F4的最佳截断值分别为7.62 kPa、8.26 kPa、11.01 kPa。
- 总胆红素异常患者肝硬度评估≥F2、≥F3、F4的假阳性率分别为44.6%、45.1%、39.6%。
- 总胆红素正常患者肝硬度评估≥F2、≥F3、F4的假阳性率分别为20.7%、17.1%、14.4%。
- 将总胆红素加入肝硬度后,纤维化分期的ROC曲线下面积无明显变化。
临床应用与阅片要点
- 阅片及报告肝硬度值时,应结合总胆红素水平判读,总胆红素异常者肝硬度值可能偏高。
- 对总胆红素异常患者采用肝硬度评估纤维化分期时,宜参考其对应的较高最佳截断值。
- 总胆红素异常患者肝硬度评估纤维化分期假阳性率较高,报告时需注意纤维化分期被高估的可能。
- 将总胆红素加入肝硬度并未改善纤维化分期的整体诊断性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the impact of intrahepatic cholestasis on liver fibrosis staging using liver stiffness measurements (LSM).
METHODS: Between July 2011 and September 2016, a total of 1197 patients with chronic hepatitis B (CHB) infection were enrolled to collect clinical, biological, 2D shear wave elastography (SWE), and histological (METAVIR scoring system) data. LSM was compared in patients with normal total bilirubin (TB) versus abnormal TB for each group of fibrosis stage, alanine aminotransferase (ALT) levels, and inflammation grade. Logistic regression and ROC analyses were performed to assess the benefit of adding TB and to LSM for fibrosis staging.
RESULTS: Nine hundred and seventy-three patients were analyzed. Within the same fibrosis stage, LSMs showed significantly higher value in patients with abnormal TB than those with normal TB. Increased LSM for abnormal TB was generally found within different sub-groups of patients (≤ F2 or ≥ F3; ALT < 2 × upper limit of normal (ULN) or ALT ≥ 2 × ULN; METAVIR activity grade ≤ 1 or ≥ 2). Patients with abnormal TB level showed higher optimal cutoff values: 10.46 kPa for ≥ F2, 10.94 kPa for ≥ F3, and 15.88 kPa for F4, than those with normal TB (7.62 kPa, 8.26 kPa, and 11.01 kPa, respectively). LSM assessed fibrosis stage (≥ F2, ≥ F3, F4) showed higher false positive rate in patients with abnormal TB level (44.6%, 45.1%, 39.6%) than those with normal TB (20.7%, 17.1%, 14.4%). However, the area under the ROC curve did not change appreciably when adding TB to LSM for fibrosis stage.
CONCLUSION: Intrahepatic cholestasis showed slight effect on LSM in patients with CHB, also leading to overestimation of liver fibrosis stages. But adding TB level to LSM did not improve the overall diagnostic performance of liver fibrosis stage.
KEY POINTS: • Intrahepatic cholestasis showed slight effect on liver stiffness measurements (LSMs) in chronic HBV patients. • Patients with abnormal total bilirubin (TB) level showed higher optimal cutoff values and false positive rate. • When taking into account intrahepatic cholestasis, the diagnostic performance of LSM for liver fibrosis staging in patients with chronic HBV infection will not improve.
引用
- Guo H, Liao M, Jin J, et al. How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy. Eur Radiol. 2019. PMID: 31673836. doi:10.1007/s00330-019-06451-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。